BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2439444)

  • 1. Mechanism of action of a Db-specific helper clone and factor in cytotoxic responses to alloantigens.
    Kwong PC; Teh HS
    Immunology; 1987 Jun; 61(2):151-7. PubMed ID: 2439444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Db-specific helper factor required for the induction of cytotoxic responses to alloantigens with the use of monoclonal antibodies specific for the helper factor or the T-cell antigen receptor.
    Kwong PC; Teh HS
    Immunology; 1987 Jun; 61(2):143-50. PubMed ID: 2954897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CTL responses to alloantigens by a Db-specific T helper clone.
    Kwong PC; Kilburn DG; Teh HS
    J Immunol; 1984 Aug; 133(2):653-9. PubMed ID: 6203972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cytotoxic lymphocyte responses by antigen-specific helper factors.
    Krowka JF; Shiozawa C; Diener E; Paetkau V; Pilarski LM
    J Immunol; 1984 Oct; 133(4):2018-24. PubMed ID: 6206146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
    Tomonari K
    J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of affinity-enriched B cells. II. Composition and B cell triggering properties of affinity-purified, antigen-specific, T cell-derived helper factor.
    Shiozawa C; Sawada S; Inazawa M; Diener E
    J Immunol; 1984 Apr; 132(4):1892-9. PubMed ID: 6199416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
    J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
    Hardt C; Diamantstein T; Wagner H
    Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
    J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A requirement for physical linkage between determinants recognized by helper molecules and cytotoxic T cell precursors in the induction of cytotoxic T cell responses.
    Krowka JF; Singh B; Fotedar A; Mosmann T; Giedlin MA; Pilarski LM
    J Immunol; 1986 May; 136(10):3561-6. PubMed ID: 2422257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for helper cell subpopulations in a genetically controlled cytolytic T lymphocyte response to the H-2Db antigen.
    French DL; Plate JM
    J Immunol; 1985 Jul; 135(1):39-46. PubMed ID: 3158704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
    Klarnet JP; Kern DE; Dower SK; Matis LA; Cheever MA; Greenberg PD
    J Immunol; 1989 Apr; 142(7):2187-91. PubMed ID: 2466890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
    Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
    Kern DE; Gillis S; Okada M; Henney CS
    J Immunol; 1981 Oct; 127(4):1323-8. PubMed ID: 6456304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.